Table 1.

Age-standardized female breast cancer mortality in relation to bioclinical factors and breast cancer screening programmes

	Coefficient	95% CI
Cardiovascular diseases	0.025	0.02 to 0.03
Diabetes and kidney diseases	0.013	0.01 to 0.02
Neoplasms	0.04	0.02 to 0.05
High LDL-c	0.63	0.48 to 0.78
Smoking	1.55	1.34 to 1.75
Secondary smoke	−0.02	−0.05 to 0.01
High BMI	−0.13	−0.21 to −0.06
Only SBE/CBE tests	Reference
MM and/or SBE/CBE tests	−4.16	−6.76 to −1.55
DMM/US and/or the previous tests	−3.64	−6.59 to −0.70
No country/pilot screening programmea	Reference
Regional-wise screening programme	−1.36	−4.89 to 2.18
National-wise screening programme	−4.41	−8.14 to −0.68

Cardiovascular diseases, diabetes and kidney disease, and neoplasms are expressed as age-standardized years lived with disability. Neoplasms estimates exclude breast cancer. High LDL-c, smoking, secondary smoke and high BMI are expressed as age-standardized summary exposure values (SEVs; range 0-100).

95 CIs, 95% confidence intervals; BMI, body mass index; CBE, clinical breast examination; DMM, digital mammography; DMM/US, digital mammography and/or ultrasound; LDL-c, low-density lipoprotein-cholesterol; MM, mammography; SBE, self-breast examination; SBE/CBE tests, self-breast and/or clinical breast examination; SEV, summary exposure value; US, ultrasound.

^aNo country programme or existence of an opportunistic or pilot screening programme.